Physician profile
Ye Ye
NPI 1821216342
$680.30
in general payments reported to CMS, 2019-2025
19 companies · $58.16 in 2025
The $58.16 reported for 2025 was less than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $133 · 2020: $64.99 · 2021: $204 · 2022: $107 · 2023: $84.47 · 2024: $29.38 · 2025: $58.16.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $172.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $172.01 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $230.45 | 2021-2025 | Teflaro |
| Heron Therapeutics, INC. | $55.87 | 2021-2022 | |
| Ethicon US, LLC | $53.77 | 2021 | |
| Tela Bio, INC. | $48.09 | 2019-2020 | |
| Organogenesis INC. | $42.77 | 2020-2022 | |
| Ambu INC. | $28.41 | 2023 | |
| Portola Pharmaceuticals, LLC | $28.33 | 2019 | |
| Smith+Nephew, INC. | $27.77 | 2020-2021 | |
| Allergan, INC. | $21.33 | 2019 | |
| Exact Sciences Corporation | $18.47 | 2023 | Cologuard Collection Kit |
| Kerecis Limited | $16.62 | 2023 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Marigen, Kerecis Omega3 Graftguide |
| Medtronic, INC. | $16.27 | 2022 | |
| Olympus America INC. | $15.98 | 2019 | |
| Paratek Pharmaceuticals, INC. | $14.15 | 2021 | |
| Qol Medical, LLC | $13.99 | 2019 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kci USA, INC. | $12.62 | 2020 | |
| Myriad Genetic Laboratories, INC. | $12.50 | 2021 | |
| Biofire Diagnostics, LLC | $11.46 | 2019 | |
| Davol INC. | $11.45 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ye Ye listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.